Dr. Jennifer Zelovitzky is the clinical director of women’s health and vitality at Medcan and leads the new perimenopause and menopause program. She’s a certified menopause practitioner and an advocate for the benefits of hormone replacement therapy.
Dr. Zelovitzky also has an unusual backstory that includes working on Bay Street before attending medical school while raising two young daughters. Here, she joins Director of Clinical Innovation Allison Hazell to talk about menopause misconceptions, the education gap that exists around women’s health-and how Medcan’s new program aims to empower women with knowledge.
RELEVANT LINKS:
For complete episode links and time-coded insights, visit the Eat Move Think episode 176 web page:
www.eatmovethinkpodcast.com/p...
bit.ly/3CNkMMd
To learn more about Medcan’s perimenopause and menopause program, contact 416.350.5900 or email clientservice@medcan.com.
Eat Move Think is produced by Ghost Bureau:
www.ghostbureau.com
TIMESTAMPS
0:00 Intro
00:50 Dr. Jennifer Zelovitzky’s journey: from a career in finance on Bay Street to clinical director of women’s health and vitality at Medcan.
07:03 Healthcare needs to be doing more for women’s health.
08:36 How we’re changing the way women’s health challenges have been stigmatized.
11:31 How much training do family physicians receive on menopause and perimenopause care?
12:29 How old are you when you enter perimenopause? Which symptoms of menopause are considered “normal,” and which warrant treatment with hormone therapy or medication?
15:29 A breakdown of the Perimenopause and Menopause Program: a 6-month multidisciplinary clinic that Dr. Zelovitzky and her team have been working hard to develop.
19:33 Hormone replacement therapy: what is it, and why has it historically been incorrectly considered to increase risk of chronic disease.
23:03 Who is a good fit for hormone replacement therapy, and what does the process at Medcan look like from a patient’s perspective?
26:05 Dr. Zelovitzky talks through the biggest misconceptions she’s heard about hormone replacement therapy.
15 июл 2024
